Logo image of GMRE

GLOBAL MEDICAL REIT INC (GMRE) Stock Fundamental Analysis

NYSE:GMRE - New York Stock Exchange, Inc. - US37954A2042 - REIT - Currency: USD

7.02  +0.08 (+1.15%)

After market: 7.02 0 (0%)

Fundamental Rating

3

Taking everything into account, GMRE scores 3 out of 10 in our fundamental rating. GMRE was compared to 130 industry peers in the Diversified REITs industry. GMRE has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, GMRE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year GMRE was profitable.
GMRE had a positive operating cash flow in the past year.
GMRE had positive earnings in 4 of the past 5 years.
GMRE had a positive operating cash flow in each of the past 5 years.
GMRE Yearly Net Income VS EBIT VS OCF VS FCFGMRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

With a Return On Assets value of 0.17%, GMRE perfoms like the industry average, outperforming 41.54% of the companies in the same industry.
GMRE has a Return On Equity of 0.41%. This is comparable to the rest of the industry: GMRE outperforms 42.31% of its industry peers.
GMRE's Return On Invested Capital of 2.18% is on the low side compared to the rest of the industry. GMRE is outperformed by 60.77% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for GMRE is in line with the industry average of 3.17%.
Industry RankSector Rank
ROA 0.17%
ROE 0.41%
ROIC 2.18%
ROA(3y)0.73%
ROA(5y)0.48%
ROE(3y)1.6%
ROE(5y)0.99%
ROIC(3y)2.29%
ROIC(5y)2.1%
GMRE Yearly ROA, ROE, ROICGMRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

With a Profit Margin value of 1.53%, GMRE perfoms like the industry average, outperforming 43.08% of the companies in the same industry.
GMRE's Profit Margin has declined in the last couple of years.
GMRE's Operating Margin of 24.17% is in line compared to the rest of the industry. GMRE outperforms 54.62% of its industry peers.
In the last couple of years the Operating Margin of GMRE has declined.
Industry RankSector Rank
OM 24.17%
PM (TTM) 1.53%
GM N/A
OM growth 3Y-9.47%
OM growth 5Y-9.28%
PM growth 3Y-61.43%
PM growth 5Y-34.4%
GM growth 3YN/A
GM growth 5YN/A
GMRE Yearly Profit, Operating, Gross MarginsGMRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

0

2. Health

2.1 Basic Checks

GMRE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for GMRE has been increased compared to 1 year ago.
Compared to 5 years ago, GMRE has more shares outstanding
GMRE has a worse debt/assets ratio than last year.
GMRE Yearly Shares OutstandingGMRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
GMRE Yearly Total Debt VS Total AssetsGMRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

GMRE has an Altman-Z score of 0.19. This is a bad value and indicates that GMRE is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.19, GMRE is doing worse than 69.23% of the companies in the same industry.
GMRE has a Debt/Equity ratio of 1.28. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of GMRE (1.28) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF N/A
Altman-Z 0.19
ROIC/WACC0.33
WACC6.57%
GMRE Yearly LT Debt VS Equity VS FCFGMRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

2.3 Liquidity

A Current Ratio of 0.24 indicates that GMRE may have some problems paying its short term obligations.
GMRE has a worse Current ratio (0.24) than 89.23% of its industry peers.
A Quick Ratio of 0.24 indicates that GMRE may have some problems paying its short term obligations.
GMRE has a Quick ratio of 0.24. This is amonst the worse of the industry: GMRE underperforms 88.46% of its industry peers.
Industry RankSector Rank
Current Ratio 0.24
Quick Ratio 0.24
GMRE Yearly Current Assets VS Current LiabilitesGMRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

4

3. Growth

3.1 Past

GMRE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -73.91%.
Measured over the past years, GMRE shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.74% on average per year.
Looking at the last year, GMRE shows a decrease in Revenue. The Revenue has decreased by -1.19% in the last year.
The Revenue has been growing by 14.44% on average over the past years. This is quite good.
EPS 1Y (TTM)-73.91%
EPS 3Y-40.51%
EPS 5Y-16.74%
EPS Q2Q%200%
Revenue 1Y (TTM)-1.19%
Revenue growth 3Y6.19%
Revenue growth 5Y14.44%
Sales Q2Q%-1.42%

3.2 Future

GMRE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.08% yearly.
Based on estimates for the next years, GMRE will show a small growth in Revenue. The Revenue will grow by 2.20% on average per year.
EPS Next Y195.8%
EPS Next 2Y92.29%
EPS Next 3Y31.9%
EPS Next 5Y23.08%
Revenue Next Year2.76%
Revenue Next 2Y3.18%
Revenue Next 3Y2.7%
Revenue Next 5Y2.2%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
GMRE Yearly Revenue VS EstimatesGMRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M
GMRE Yearly EPS VS EstimatesGMRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 -0.4 -0.6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 117.00, GMRE can be considered very expensive at the moment.
GMRE's Price/Earnings ratio is a bit more expensive when compared to the industry. GMRE is more expensive than 60.77% of the companies in the same industry.
When comparing the Price/Earnings ratio of GMRE to the average of the S&P500 Index (27.91), we can say GMRE is valued expensively.
A Price/Forward Earnings ratio of 47.46 indicates a quite expensive valuation of GMRE.
GMRE's Price/Forward Earnings is on the same level as the industry average.
GMRE's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 37.11.
Industry RankSector Rank
PE 117
Fwd PE 47.46
GMRE Price Earnings VS Forward Price EarningsGMRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

GMRE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. GMRE is cheaper than 63.08% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.91
GMRE Per share dataGMRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GMRE's earnings are expected to grow with 31.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.6
PEG (5Y)N/A
EPS Next 2Y92.29%
EPS Next 3Y31.9%

More info and screens

5

5. Dividend

5.1 Amount

GMRE has a Yearly Dividend Yield of 8.53%, which is a nice return.
Compared to an average industry Dividend Yield of 6.46, GMRE pays a better dividend. On top of this GMRE pays more dividend than 82.31% of the companies listed in the same industry.
GMRE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 8.53%

5.2 History

The dividend of GMRE decreases each year by -0.24%.
GMRE has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of GMRE decreased in the last 3 years.
Dividend Growth(5Y)-0.24%
Div Incr Years0
Div Non Decr Years2
GMRE Yearly Dividends per shareGMRE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

3110.89% of the earnings are spent on dividend by GMRE. This is not a sustainable payout ratio.
DP3110.89%
EPS Next 2Y92.29%
EPS Next 3Y31.9%
GMRE Yearly Income VS Free CF VS DividendGMRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M
GMRE Dividend Payout.GMRE Dividend Payout, showing the Payout Ratio.GMRE Dividend Payout.PayoutRetained Earnings

More info and screens

GLOBAL MEDICAL REIT INC

NYSE:GMRE (7/29/2025, 8:04:00 PM)

After market: 7.02 0 (0%)

7.02

+0.08 (+1.15%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners70.11%
Inst Owner Change0.06%
Ins Owners0.09%
Ins Owner Change2.09%
Market Cap469.50M
Analysts78.75
Price Target9.28 (32.19%)
Short Float %4.21%
Short Ratio3.58
Dividend
Industry RankSector Rank
Dividend Yield 8.53%
Yearly Dividend0.99
Dividend Growth(5Y)-0.24%
DP3110.89%
Div Incr Years0
Div Non Decr Years2
Ex-Date06-20 2025-06-20 (0.15)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.27%
Min Revenue beat(2)-4.08%
Max Revenue beat(2)-0.46%
Revenue beat(4)0
Avg Revenue beat(4)-2.52%
Min Revenue beat(4)-4.08%
Max Revenue beat(4)-0.46%
Revenue beat(8)1
Avg Revenue beat(8)-2.89%
Revenue beat(12)2
Avg Revenue beat(12)-2.2%
Revenue beat(16)3
Avg Revenue beat(16)-2.04%
PT rev (1m)-2.02%
PT rev (3m)-13.13%
EPS NQ rev (1m)200%
EPS NQ rev (3m)28.59%
EPS NY rev (1m)60%
EPS NY rev (3m)28.89%
Revenue NQ rev (1m)-0.48%
Revenue NQ rev (3m)-2.84%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-2.63%
Valuation
Industry RankSector Rank
PE 117
Fwd PE 47.46
P/S 3.4
P/FCF N/A
P/OCF 6.9
P/B 0.91
P/tB 1.02
EV/EBITDA 12.91
EPS(TTM)0.06
EY0.85%
EPS(NY)0.15
Fwd EY2.11%
FCF(TTM)-0.9
FCFYN/A
OCF(TTM)1.02
OCFY14.49%
SpS2.07
BVpS7.74
TBVpS6.85
PEG (NY)0.6
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.17%
ROE 0.41%
ROCE 2.76%
ROIC 2.18%
ROICexc 2.19%
ROICexgc 2.35%
OM 24.17%
PM (TTM) 1.53%
GM N/A
FCFM N/A
ROA(3y)0.73%
ROA(5y)0.48%
ROE(3y)1.6%
ROE(5y)0.99%
ROIC(3y)2.29%
ROIC(5y)2.1%
ROICexc(3y)2.3%
ROICexc(5y)2.11%
ROICexgc(3y)2.52%
ROICexgc(5y)2.3%
ROCE(3y)2.9%
ROCE(5y)2.66%
ROICexcg growth 3Y-3.14%
ROICexcg growth 5Y-2.71%
ROICexc growth 3Y-3.1%
ROICexc growth 5Y-2.82%
OM growth 3Y-9.47%
OM growth 5Y-9.28%
PM growth 3Y-61.43%
PM growth 5Y-34.4%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF N/A
Debt/EBITDA 7.55
Cap/Depr 235.06%
Cap/Sales 92.7%
Interest Coverage 1.25
Cash Conversion 77.34%
Profit Quality N/A
Current Ratio 0.24
Quick Ratio 0.24
Altman-Z 0.19
F-Score4
WACC6.57%
ROIC/WACC0.33
Cap/Depr(3y)155.62%
Cap/Depr(5y)302.85%
Cap/Sales(3y)63.21%
Cap/Sales(5y)120.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73.91%
EPS 3Y-40.51%
EPS 5Y-16.74%
EPS Q2Q%200%
EPS Next Y195.8%
EPS Next 2Y92.29%
EPS Next 3Y31.9%
EPS Next 5Y23.08%
Revenue 1Y (TTM)-1.19%
Revenue growth 3Y6.19%
Revenue growth 5Y14.44%
Sales Q2Q%-1.42%
Revenue Next Year2.76%
Revenue Next 2Y3.18%
Revenue Next 3Y2.7%
Revenue Next 5Y2.2%
EBIT growth 1Y-10.08%
EBIT growth 3Y-3.87%
EBIT growth 5Y3.82%
EBIT Next Year183.69%
EBIT Next 3Y44.02%
EBIT Next 5Y34.85%
FCF growth 1Y-9.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.34%
OCF growth 3Y0.52%
OCF growth 5Y13.97%